Goldman Sachs Group Inc Regeneron Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 609,043 shares of REGN stock, worth $427 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
609,043
Previous 688,579 11.55%
Holding current value
$427 Million
Previous $724 Million 11.53%
% of portfolio
0.11%
Previous 0.12%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $81.5 Million - $95.6 Million
-79,536 Reduced 11.55%
609,043 $640 Million
Q2 2024

Aug 13, 2024
BUY
$883.2 - $1071.19 $272 Million - $330 Million
307,658 Added 80.77%
688,579 $724 Million
Q1 2024

May 15, 2024
BUY
$902.69 - $993.35 $8.25 Million - $9.08 Million
9,136 Added 2.46%
380,921 $367 Million
Q4 2023

Feb 13, 2024
SELL
$775.18 - $881.7 $16.6 Million - $18.9 Million
-21,385 Reduced 5.44%
371,785 $327 Million
Q3 2023

May 14, 2024
BUY
$692.45 - $844.37 $14.8 Million - $18.1 Million
21,385 Added 5.75%
393,170 $324 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $75.4 Million - $91.9 Million
-108,860 Reduced 21.68%
393,170 $324 Million
Q2 2023

May 14, 2024
BUY
$700.03 - $830.35 $46.4 Million - $55 Million
66,252 Added 15.2%
502,030 $361 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $46.4 Million - $55 Million
66,252 Added 15.2%
502,030 $361 Million
Q1 2023

May 14, 2024
SELL
$680.49 - $826.97 $86.4 Million - $105 Million
-126,927 Reduced 22.56%
435,778 $358 Million
Q1 2023

May 11, 2023
SELL
$680.49 - $826.97 $86.4 Million - $105 Million
-126,927 Reduced 22.56%
435,778 $358 Million
Q4 2022

May 14, 2024
BUY
$705.89 - $766.39 $92.3 Million - $100 Million
130,790 Added 30.28%
562,705 $406 Million
Q4 2022

Feb 13, 2023
BUY
$705.89 - $766.39 $92.3 Million - $100 Million
130,790 Added 30.28%
562,705 $406 Million
Q3 2022

May 14, 2024
BUY
$573.97 - $724.32 $9.64 Million - $12.2 Million
16,790 Added 4.04%
431,915 $298 Million
Q3 2022

Nov 10, 2022
BUY
$573.97 - $724.32 $9.64 Million - $12.2 Million
16,790 Added 4.04%
431,915 $298 Million
Q2 2022

May 14, 2024
BUY
$548.35 - $738.84 $23.8 Million - $32 Million
43,340 Added 11.66%
415,125 $245 Million
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $20.6 Million - $27.8 Million
37,578 Added 9.95%
415,125 $245 Million
Q1 2022

May 16, 2022
BUY
$595.12 - $698.43 $1.13 Million - $1.33 Million
1,902 Added 0.51%
377,547 $264 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $41.9 Million - $51.8 Million
-77,147 Reduced 17.04%
375,645 $237 Million
Q3 2021

Nov 10, 2021
BUY
$574.03 - $680.96 $260 Million - $308 Million
452,792 New
452,792 $274 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email